News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meury William
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Meury William (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 35,000 shares
@ $20.4556, valued at
$715.9k
Sold 24,000 shares
@ $20.4563, valued at
$491k
Sold 24,000 shares
@ $20.4547, valued at
$490.9k
Exercised 24,000 options to buy
@ $9.47, valued at
$227.3k
Exercised 24,000 options to buy
@ $7.88, valued at
$189.1k
Exercised 35,000 options to buy
@ $7.11, valued at
$248.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 7,434 shares
@ $0
Disposed/sold 25,201 restricted stock units
@ $0
Disposed/sold 19,278 options
@ $224, valued at
$4.3M
Disposed/sold 1 options
@ $63.51, valued at
$63.5
Disposed/sold 1,387 options
@ $72.07, valued at
$100k
Disposed/sold 1,246 options
@ $80.2, valued at
$99.9k
Disposed/sold 509 options
@ $196.16, valued at
$99.8k
Disposed/sold 16,081 options
@ $63.51, valued at
$1M
Disposed/sold 10,089 options
@ $72.07, valued at
$727.1k
Disposed/sold 21,621 options
@ $80.2, valued at
$1.7M
Disposed/sold 12,304 options
@ $196.16, valued at
$2.4M
|
|
| 04/07/2020 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 855 shares
@ $175.71, valued at
$150.2k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2019 |
4
| Meury William (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 24,000 options to buy
@ $7.88, valued at
$189.1k
|
|
| 04/05/2019 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 871 shares
@ $145.71, valued at
$126.9k
|
|
| 01/03/2019 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 1,531 shares
@ $133.66, valued at
$204.6k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/21/2018 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Sold 24,425 shares
@ $154.59, valued at
$3.8M
Exercised 1,467 options to buy
@ $68.11, valued at
$99.9k
Exercised 19,785 options to buy
@ $68.11, valued at
$1.3M
|
|
| 04/05/2018 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 819 shares
@ $164.74, valued at
$134.9k
|
|
| 02/16/2018 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Sold 25,079 shares
@ $157.18, valued at
$3.9M
Sold 1,200 shares
@ $157.6, valued at
$189.1k
Sold 1,700 shares
@ $158.78, valued at
$269.9k
Sold 2,400 shares
@ $159.82, valued at
$383.6k
Sold 1,000 shares
@ $161.1, valued at
$161.1k
Sold 4,700 shares
@ $162.22, valued at
$762.4k
Sold 7,200 shares
@ $163.04, valued at
$1.2M
Sold 2,000 shares
@ $164.62, valued at
$329.2k
Sold 13,600 shares
@ $165.16, valued at
$2.2M
Exercised 1,957 options to buy
@ $51.07, valued at
$99.9k
Exercised 2,765 options to buy
@ $51.07, valued at
$141.2k
|
|
| 01/02/2018 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 1,611 shares
@ $163.58, valued at
$263.5k
|
|
| 12/04/2017 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Sold 9,272 shares
@ $173.89, valued at
$1.6M
Sold 2,535 shares
@ $173.89, valued at
$440.8k
Exercised 9,272 options to buy
@ $78.88, valued at
$731.4k
Exercised 2,535 options to buy
@ $78.88, valued at
$200k
|
|
| 10/30/2017 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Exercised 9,321 options to buy
@ $0 |
|
| 05/16/2017 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc |
| 04/04/2017 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc |
| 02/14/2017 |
4
| Meury William (Chief Commercial Officer) has filed a Form 4 on Allergan plc |
| 05/17/2016 |
4
| Meury William (Chief Communication Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 713 shares
@ $223.35, valued at
$159.2k
Paid exercise price by delivering 510 shares
@ $223.35, valued at
$113.9k
|
|
| 03/04/2016 |
4/A
| Meury William (EVP & Pres Branded Pharma) has filed a Form 4 on Allergan plc|
Txns:
| Granted 47,165 shares
@ $0 |
|
| 12/28/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2015 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Paid exercise price by delivering 437 shares
@ $296.6, valued at
$129.6k
Paid exercise price by delivering 773 shares
@ $296.6, valued at
$229.3k
Paid exercise price by delivering 671 shares
@ $296.6, valued at
$199k
|
|
| 04/02/2015 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Paid exercise price by delivering 3,848 shares
@ $296.19, valued at
$1.1M
Paid exercise price by delivering 1,788 shares
@ $296.19, valued at
$529.6k
|
|
| 12/22/2014 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Gifted 98 shares
@ $0 |
|
| 12/10/2014 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Paid exercise price by delivering 1,332 shares
@ $266.59, valued at
$355.1k
Paid exercise price by delivering 2,469 shares
@ $266.59, valued at
$658.2k
|
|
| 12/01/2014 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Sold 4,550 shares
@ $269.1443, valued at
$1.2M
Exercised 7,083 options to buy
@ $90.06, valued at
$637.9k
|
|
| 07/03/2014 |
4
| Meury William (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Granted 79,406 shares
@ $0
Granted 7,084 options to buy
@ $90.06, valued at
$638k
Granted 11,807 options to buy
@ $109.12, valued at
$1.3M
Granted 11,807 options to buy
@ $78.88, valued at
$931.3k
Granted 4,723 options to buy
@ $51.07, valued at
$241.2k
Granted 18,892 options to buy
@ $66.2, valued at
$1.3M
Granted 21,253 options to buy
@ $68.11, valued at
$1.4M
Granted 16,081 options to buy
@ $63.51, valued at
$1M
Granted 11,476 options to buy
@ $72.07, valued at
$827.1k
Granted 22,868 options to buy
@ $80.2, valued at
$1.8M
Granted 12,814 options to buy
@ $196.16, valued at
$2.5M
|
|
|
|
|